Why Is MEDLINE INC Class A (MDLN) Stock Up Today?

Medline Inc. shares surged 18.36% to close at $40.35 on Wednesday. The primary driver was a strong third-quarter earnings report that exceeded expectations, coupled with the announcement of a new $1 billion share repurchase program.

What Happened

Medline reported third-quarter 2026 adjusted earnings per share of $0.44, surpassing the consensus estimate of $0.35. Revenue for the quarter reached $7.856 billion, beating the projected $7.723 billion and representing a 10.4% year-over-year increase. The company also provided a full-year 2026 adjusted EBITDA outlook of $3.3 billion to $3.4 billion. Management outlined plans for high single-digit net sales growth in 2027. Alongside the results, Medline launched a share repurchase program authorized for up to $1 billion. The stock recorded its best intraday gain following the release, with the company publishing its earnings presentation on November 4, 2026.

What The Data Shows

The stock printed 58 fresh 52-week highs on November 4, 2026. Over the last eight trading sessions, MDLN has accumulated a 19.8% gain, rising from $33.69 to the current level. The company’s market capitalization stands at $29.5 billion with a trailing twelve-month revenue growth rate of 12.1%. The current price-to-earnings ratio is 42.8, and the net margin is 2.3%. The 52-week trading range spans from $31.37 to $50.88. Unusual options activity in the last 36 hours included one notable print with $534,000 in call premium and no put premium. Recent insider filings show five sales totaling $1.2 billion over the last 90 days, with the most recent transaction on October 13, 2026. Gic Private Ltd, a 10% holder, executed sales in August and October 2026.

What To Watch

Investors will monitor the company’s execution of the new buyback program and its ability to maintain the high single-digit growth trajectory for 2027. The stock’s position near its 52-week high suggests continued focus on valuation metrics and future margin pressures.